ExodusPoint Capital Management’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$23.6M Buy
+25,699
New +$26.1M 0.19% 76
2025
Q3
Sell
-23,579
Closed -$18.4M 1803
2025
Q2
$18.4M Buy
+23,579
New +$18.3M 0.16% 126
2024
Q4
Sell
-14,285
Closed -$12.7M 1805
2024
Q3
$12.7M Sell
14,285
-13,739
-49% -$12.4M 0.08% 195
2024
Q2
$25.4M Buy
+28,024
New +$22.4M 0.17% 97
2024
Q1
Sell
-13,478
Closed -$9.59M 1755
2023
Q4
$7.86M Sell
13,478
-29,910
-69% -$17.5M 0.05% 247
2023
Q3
$23.3M Buy
+43,388
New +$22.4M 0.22% 81
2022
Q4
Sell
-49,501
Closed -$16M 1908
2022
Q3
$16M Sell
49,501
-37,452
-43% -$11.9M 0.21% 101
2022
Q2
$28.2M Buy
+86,953
New +$26.1M 0.35% 36
2022
Q1
Sell
-27,582
Closed -$7.62M 2459
2021
Q4
$7.62M Buy
27,582
+16,694
+153% +$4.23M 0.08% 289
2021
Q3
$2.52M Sell
10,888
-9,511
-47% -$2.35M 0.03% 635
2021
Q2
$4.68M Sell
20,399
-14,736
-42% -$2.96M 0.05% 382
2021
Q1
$6.56M Buy
+35,135
New +$6.87M 0.1% 203
2020
Q4
Sell
-146,672
Closed -$21.7M 2192
2020
Q3
$21.7M Buy
146,672
+114,932
+362% +$17.8M 0.43% 25
2020
Q2
$5.21M Buy
+31,740
New +$4.87M 0.14% 154
2019
Q3
Sell
-3,741
Closed -$414K 1498
2019
Q2
$414K Buy
+3,741
New +$441K 0.02% 553
2019
Q1
Sell
-2,106
Closed -$244K 723
2018
Q4
$244K Buy
+2,106
New +$235K 0.02% 227

Other funds holding LLY

ExodusPoint Capital Management's LLY Position: Q1 2026 in Review

ExodusPoint Capital Management opened a new position in Eli Lilly (LLY) in Q1 2026: 25,699 shares worth $23.6M. The stake represents 0.19% of the portfolio and ranks #76 among its holdings. This is a return to the name: ExodusPoint Capital Management previously reported a position in LLY as recently as Q2 2025.

ExodusPoint Capital Management first reported a position in LLY in Q4 2018 and has held it in 16 quarters since. The position peaked at $28.2M in Q2 2022. 4,353 funds tracked by Wall St. Rank hold LLY as of Q1 2026.

  • ExodusPoint Capital Management held 25,699 shares of Eli Lilly worth $23.6M as of Q1 2026.
  • Eli Lilly was a new ExodusPoint Capital Management position in Q1 2026.
  • Eli Lilly made up 0.19% of ExodusPoint Capital Management's portfolio in Q1 2026, its #76 holding.
  • ExodusPoint Capital Management first reported a position in Eli Lilly in Q4 2018 and has held it in 16 quarters since.
  • ExodusPoint Capital Management's Eli Lilly position peaked at $28.2M in Q2 2022.
  • 4,353 funds tracked by Wall St. Rank held Eli Lilly as of Q1 2026.

Based on ExodusPoint Capital Management's 13F filing for Q1 2026, filed 14 May 2026.